ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0997

Citrullinated Vimentin Induces Epigenetic Memory of the Innate Immune System

Katerina Laskari1, Shweta Sabu2, Oliver Distler3, Emmanuel Karouzakis2 and Michel Neidhart2, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland

Meeting: ACR Convergence 2021

Keywords: innate immunity, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Innate Immunity Poster (0992–1006)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: During trained immunity, monocytes and macrophages undergo a functional and transcriptional reprogramming toward activation, which is induced by a priming stimulus and results in enhanced responsiveness to subsequent triggers. We aimed to investigate if citrullinated vimentin (c-vimentin), a damage-associated pattern in rheumatoid arthritis (RA), induces trained immunity in vitro in healthy individuals.

Methods: Monocytes isolated from the peripheral blood (EDTA blood, n=22; buffy coats, n=6) of healthy donors by Ficoll-paque centrifugation and negative selection, were stimulated with c-vimentin (0.1 μg/ml) for 24h and re-stimulated 5 days later with the lipopolysaccharide of E.coli (LPS) (10 ng/ml). Protein release (ELISA, Western blot) and gene expression levels (RNA sequencing) were measured. Chromatin accessibility changes were assessed by ATAC sequencing. The methylation of histone H3 at lysine 4 (H3K4) was examined by chromatin immunoprecipitation. The ligand-receptor glycocapture technology was used to identify candidate cell surface targets of c-vimentin.

Results: Priming with c-vimentin induced training in human monocytes, as suggested by the significantly increased levels of secreted interleukin-6 (IL-6), the chemokine CXCL1 and CCL20/Macrophage Inflammatory Protein 3a, upon restimulation with LPS (1.29-2.32-fold increase, n=22, all p< 0.001). A significant increase in proinflammatory cytokine and chemokine expression was also shown in RNA sequencing (n=4), beside up-regulation of genes related to glucose and lipid metabolism as well as epigenetic effectors. Exposition to c-vimentin induced chromatin rearrangement (n=4), with increased proportion of accessible promoters (14.4% on day 6 vs. 2.4% on day 1), and a positive correlation to gene expression (r=0.35). Besides, c-vimentin induced H3K4 methylation with increased levels of this mark in the promoter of the IL-6 gene (n=6, p=0.020). Interestingly, we observed an upregulation in the expression of histone methyltransferase PRDM8 (37-fold, SD +/-10.8). At the same time, by inhibiting histone methyltransferases with methylthioadenosine (1 mM), trained immunity was reversed (8.43-fold decrease in IL-6 release, n=6, p=0.031). A shift in metabolism was supported by high lactate production measured by ELISA in the trained cells (n=9, p=0.004), while by inhibiting the metabolic pathway of glycolysis with 2-deoxyglucose (11 mM), the induction of trained immunity could be counteracted (5.32-fold decrease in IL-6 release, n=6, p=0.030). Finally, STING was identified as cell surface receptor for the ligand c-vimentin. Indeed, c-vimentin induced activation of TBK1, which is implicated in the STING signaling pathway, by phosphorylation, while STING inhibition with the covalent small molecule H151 (2 μM) abolished this effect, and decreased IL-6 release (1.61-fold decrease, n=5, p=0.051).

Conclusion: C-vimentin induces epigenetic and metabolic changes in monocytes, probably through a STING and TBK1-dependent activation, resulting in enhanced cytokine and chemokine production upon restimulation. Inhibition of the STING signaling pathway may be a novel therapeutic target against myeloid activation in RA.


Disclosures: K. Laskari, None; S. Sabu, None; O. Distler, AbbVie, 12, Project scoring fee for Rheumatology Grant, Amgen, 2, Eli Lilly, 2, Pfizer Inc, 2; E. Karouzakis, None; M. Neidhart, None.

To cite this abstract in AMA style:

Laskari K, Sabu S, Distler O, Karouzakis E, Neidhart M. Citrullinated Vimentin Induces Epigenetic Memory of the Innate Immune System [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/citrullinated-vimentin-induces-epigenetic-memory-of-the-innate-immune-system/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/citrullinated-vimentin-induces-epigenetic-memory-of-the-innate-immune-system/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology